Eno Latifi, Ph.D.

Eno is an integrated solutions strategy director at Parexel and a clinical subject matter expert in immunology and inflammatory disorders, rheumatology, and rare diseases. With more than 17 years of clinical and scientific experience across the clinical research industry and academia, he helps clients develop and optimize clinical trial strategies from early through late-phase development. His expertise spans clinical trial design, regulatory strategy, study management, and operational delivery.

Eno has deep therapeutic expertise in rheumatology, dermatology, gastroenterology, allergy, and rare diseases, complemented by clinical experience in cell and gene therapy, CAR T-cell therapy, oncology, vaccines, neurology, metabolic disorders, cardiovascular disease, and kidney disease. This broad perspective enables him to bring scientific, clinical, and operational considerations together when advising clients on complex development programs.

Work Experience
Eno has built his career on a strong foundation of clinical and scientific expertise. His experience includes translational medicine, laboratory immunology, biomarker discovery, bioanalytical sciences, genomics, flow cytometry, and safety laboratory operations. He also brings experience in laboratory technology and regulatory affairs, protocol optimization, vendor management, and financial planning and budgeting. Together, these capabilities allow him to approach clinical development challenges from both a scientific and operational perspective.

Education
Eno earned his Ph.D. in biochemistry, nutrition, and biostatistics from Wayne State University in Detroit, Michigan. He also holds an M.Sc. in nutrition biochemistry, with a focus on statistics and business administration, from the same institution.